Collegium Pharmaceutical, Inc. COLL Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s financing cash flow?
- Collegium Pharmaceutical, Inc. (COLL) reported financing cash flow of -$21.34M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s financing cash flow changed year-over-year?
- Collegium Pharmaceutical, Inc.'s financing cash flow increased by 15.4% year-over-year, from -$25.24M to -$21.34M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s financing cash flow?
- Over 2 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s financing cash flow has grown at a 11.1% compound annual growth rate (CAGR), from -$89.3M to -$110.25M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.